KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Debt to Equity (2017 - 2025)

Astrana Health (ASTH) has disclosed Debt to Equity for 14 consecutive years, with $1.33 as the latest value for Q4 2025.

  • Quarterly Debt to Equity rose 118.56% to $1.33 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.33 through Dec 2025, up 118.56% year-over-year, with the annual reading at $1.33 for FY2025, 118.56% up from the prior year.
  • Debt to Equity hit $1.33 in Q4 2025 for Astrana Health, down from $1.35 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.35 in Q3 2025 to a low of $0.35 in Q3 2023.
  • Historically, Debt to Equity has averaged $0.57 across 5 years, with a median of $0.45 in 2021.
  • Biggest five-year swings in Debt to Equity: crashed 60.33% in 2021 and later soared 119.27% in 2025.
  • Year by year, Debt to Equity stood at $0.4 in 2021, then fell by 7.35% to $0.37 in 2022, then increased by 20.47% to $0.45 in 2023, then soared by 35.07% to $0.61 in 2024, then surged by 118.56% to $1.33 in 2025.
  • Business Quant data shows Debt to Equity for ASTH at $1.33 in Q4 2025, $1.35 in Q3 2025, and $0.54 in Q2 2025.